Average Co-Inventor Count = 2.81
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alnylam Pharmaceuticals, Inc. (11 from 445 patents)
11 patents:
1. 12031133 - GNAQ targeted dsRNA compositions and methods for inhibiting expression
2. 11827883 - Dosages and methods for delivering lipid formulated nucleic acid molecules
3. 11806360 - Compositions and methods for treating transthyretin (TTR) mediated amyloidosis
4. 10954516 - GNAQ targeted dsRNA compositions and methods for inhibiting expression
5. 10246708 - Dosages and methods for delivering lipid formulated nucleic acid molecules
6. 9963700 - GNAQ targeted dsRNA compositions and methods for inhibiting expression
7. 9566295 - GNAQ targeted dsRNA compositions and methods for inhibiting expression
8. 9339513 - Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
9. 8889644 - GNAQ targeted dsRNA compositions and methods for inhibiting expression
10. 8859516 - Lipid formulated compositions and methods for inhibiting expression of Eg5 and VEGF genes
11. 8324368 - GNAQ targeted dsRNA compositions and methods for inhibiting expression